Gene polymorphisms of the renin-angiotensin-aldosterone system and the risk of ischemic stroke: A role of the A1166C/AT1 gene variant

Journal of Hypertension

Volumn 22, Issue 11, 2004, Pages 2129-2134

  Rubattu, Speranza ^a,b   Di Angelantonio, Emanuele ^c   Stanzione, Rosita ^a   Zanda, Bastianina ^d   Evangelista, Anna ^a   Pirisi, Angelo ^d   De Paolis, Paola ^e   Cota, Linda ^b   Brunetti, Ercole ^e   Volpe, Massimo ^a,b  

^a IRCCS NEUROMED   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITY OF SASSARI   (Italy)

^e IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

Author keywords

Angiotensin II receptor; Genetics; Hypertension; Ischemic stroke

Indexed keywords

ALDOSTERONE; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN RECEPTOR; ANGIOTENSINOGEN; CYTOCHROME P450; DIPEPTIDYL CARBOXYPEPTIDASE; RENIN;

ADULT; AGED; ALLELE; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; DOMINANT INHERITANCE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SOUTHERN EUROPE;

EID: 7744230271     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200411000-00015     Document Type: Article

References (34)

1. Hassan A, Markus H. Genetics and ischemic stroke. Brain 2000; 123:1784-1812.
2. Rubattu S, Giliberti R, Volpe M. Etiology and pathophysiology of stroke as a complex trait. Am J Hypertens 2000; 13:1139-1148.
3. Rubattu S, Sianzione R, Di Angelantonio E, Evangelista A, Zanda B, Tarasi D, et al. Polymorphisms of the atrial natriuretic peptide gene and the risk of ischemic stroke in humans. Sirote 2004; 35:814-818.
4. Benndorf R, Boger RH, Ergun S, Steenpass A, Wieland T. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells. Circ Res 2003; 93:438-447.
5. Paquet JL, Baudouin-Legros M, Btunelle G, Meyer P. Angiotensin II-induced proliferation of aortic myocytes in spontaneously hypertensive rats. J Hypertens 1990; 8:565-572.
6. Takami S, Imai Y, Katsuya T, Ohkubo T, Tsuji K, Satoh H, et al. Gene polymorphisms of the renin-angiotensin system associates with risk for lacunar infarction. The Ohasama study. Am J Hypertens 2000; 13:121-127.
7. Tiret L, Blanc H, Ruidavets JB, Arveiler D, Luc G, Jeunemaitre X, et al. Gene polymorphisms of the renin-angiotensin system in relation to hypertension and parental history of myocardial infarction and stroke: the PEGASE study. J Hypertens 1998; 16:37-44.
8. Tiret L, Ricard S, Poirier O, Arveiler D, Cambou JP, Luc G, et al. Genetic variation at the angiotensinogen locus in relation to high blood pressure and myocardial infarction: the ECTIM study. J Hypertens 1995; 13: 311-317.
9. Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer M, Grodstein F, La Motte F, et al. A prospective evaluation of an angiotensin-converting enzyme gene polymorphism and the risk of ischemic heart diseases. N Engl J Med 1993; 332:706-711.
10. Kupari M, Hautanen A, Lankinen L, Koskinen P, Virolainen J, Nikkila H, White PC. Associations between human aldosterone synthase (CYP11B2) gene polymorphisms and left ventricular size, mass and function. Circulation 1998; 97:569-575.
11. Bonnardeaux A, Davies E, Jeunemaitre X, Fery I, Charru A, Clauser E, et al. Angiotensin II type I receptor gene polymorphisms in human essential hypertension. Hypertension 1994; 24:63-69.
12. Mickey R, Greenland S. The impact of confounder selection criteria on effect estimation. Am J Epidemiol 1989; 129:125-137.
13. Unger T. The role of the renin-angiotensin system in the development of cardiovascular disease. Am J Cardiol 2002; 89(suppl):3A-10A.
14. Wang J-G, Staessen JA. Genetic polymorphisms in the renin-angiotensin system: relevance for susceptibility to cardiovascular disease. Eur J Pharmacol 2000; 410:289-302.
15. Volpe M, Savoia C, De Paolis P, Ostrowska B, Tarasi D, Rubattu S. The renin-angiotensin system as a risk factor and therapeutic target for cardiovascular and renal disease. J Am Soc Nephrol 2002; 13:S173-S178.
16. Iadecola C, Gorelick PB. Hypertension, angiotensin, and stroke: beyond blood pressure. Stroke 2004; 35:348-350.
17. Kainulainen K, Perola M, Terwilliger J, Koskenvuo M, Syvanen AC, Vartiainen E, et al. Evidence for involvement of the type I angiotensin II receptor locus in essential hypertension. Hypertension 1999; 33:844-849.
18. Castellano M, Glorioso N, Cusi D, Sarzant R, Fabris B, Opocher G, et al. Genetic polymorphisms of the renin-angiotensin-aldosterone system and arterial hypertension in the Italian population: the GENIPER Project. J Hypertens 2003; 21:1853-1860.
19. Osterop APRM, Kofflard MJM, Sandkuijl LA, ten Cate FJ, Krams R, Schalekamp MADH, Danser AHJ. AT1 receptor A/C1166 polymorphism contributes to cardiac hypertrophy in subjects with hypertrophic cardiomyopathy. Hypertension 1998; 32:825-830.
20. Jones A, Dhamrait SS, Payne JR, Hawe E, Li P, Toor IS, et al. Genetic variants of angiotensin II receptors and cardiovascular risk in hypertension. Hypertension 2003; 42:500-506.
21. Benetos A, Topouchian J, Ricard S, Gautier S, Bonnardeaux A, Asmar R, et al. Influence of angiotensin II type I receptor polymorphism on aortic stiffness in never-treated hypertensive patients. Hypertension 1995; 26:44-47.
22. Doria A, Onuma T, Warram JH, Krolewski AS. Synergistic effect of angiotensin II type I receptor genotype and poor glycemic control on risk of nephropathy in IDDM. Diabetologia 1997; 40:1293-1299.
23. Dai WJ, Funk A, Herdegen T, Linger T, Culman J. Blockade of central angiotensin AT1 receptors improves neurological outcome and reduces expression of AP-1 transcription factors after focal brain ischemia in rats. Stroke 1999; 30:23191-2399.
24. Von Lutterotti N, Camargo MJ, Campbell WG Jr, Mueller FB, Timmermans PB, Sealey JE, Laragh JH. Angiotensin II receptor antagonist delays renal damage and stroke in salt-loaded Dahl salt-sensitive rats. J Hypertens 1992; 10:949-957.
25. Stier CT Jr, Adler LA, Levine S, Chander PN. Stroke prevention by losartan in stroke-prone spontaneously hypertensive rats. J Hypertens 1993; 11(suppl):S37-S42.
26. Kjeldsen SE, Dahlof B, Devereux RB, Julius S, Arup P, Edelman J, et al. LIFE (Losartan Intervention for Endpoint Reduction) Study Group. Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy. JAMA 2002; 288:1491-1498.
27. Lithell H, Hansson L, Skoog I, Elmfeldt D, Hofman A, Olofsson B, et al. SCOPE Study Group. The study on cognition and prognosis in the elderly (SCOPE): principal results of a randomized double-blind intervention. J Hypertens 2003; 21:875-886.
28. Hindorff LA, Heckbert SR, Tracy R, Tang Z, Psaty BM, Edwards KL, et al. Angiotensin II type I receptor polymorphisms in the Cardiovascular Health Study: relation to blood pressure, ethnicity, and cardiovascular events. Am J Hypertens 2002; 15:1050-1056.
29. Amant C, Hamon M, Bauters C, Richard F, Helbecque N, McFadden EP, et al. The angiotensin II type I receptor gene polymorphism is associated with coronary artery vasoconstriction. J Am Coll Cardiol 1997; 29:486-490.
30. van Geel PP, Pinto YM, Voors AA, Buikema H, Oosterga M, Crijns HJGM, van Gilst WH. Angiotensin II type 1 receptor A1166C gene polymorphism is associated with an increased response to angiotensin II in human arteries. Hypertension 2000; 35:717-721.
31. Miller JA, Thai K, Scholey JW. Angiotensin II type I receptor gene polymorphism predicts response to losartan and angiotensin II. Kidney Int 1999; 56:2173-2180.
32. Duncan JA, Scholey JW, Miller JA. Angiotensin II type I receptor gene polymorphisms in humans: physiology and pathophysiology of the genotypes. Curr Opin Nephrol Hypertens 2001; 10:111-116.
33. Zee RYL, Ridker PM, Stampfer M, Hennekens CH, Lindpaintner K. Prospective evaluation of the angiotensin-converting enzyme insertion-deletion polymorphism and the risk of stroke. Circulation 1999; 99:340-343.
34. Chapman CM, Palmer LJ, McQuillan BM, Hung J, Burley J, Hunt C, et al. Polymorphisms in the angiotensinogen gene are associated with carotid intimal-medial thickening in females from a community-based population. Atherosclerosis 2001; 159:209-217.